Evidence map›Paper›PMID 32983042›Full record

ArticleFrontiers in microbiology2020

A Plumieridine-Rich Fraction From

Eden Silva E Souza, Vanessa de Abreu Barcellos, Nicolau Sbaraini, Júlia Catarina Vieira Reuwsaat, Rafael de Oliveira Schneider, Adriana Corrêa da Silva, Ane Wichine Acosta Garcia, Gilsane Lino von Poser, Euzébio Guimarães Barbosa, João Paulo Matos Santos Lima and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Eden Silva E SouzaBioinformatics Multidisciplinary Environment, Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Vanessa de Abreu BarcellosCentro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Nicolau SbarainiCentro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Júlia Catarina Vieira ReuwsaatCentro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Rafael de Oliveira SchneiderCentro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Adriana Corrêa da SilvaCentro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Ane Wichine Acosta GarciaCentro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Gilsane Lino von PoserDepartment of Pharmacy, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Euzébio Guimarães BarbosaDepartment of Pharmacy, Universidade Federal do Rio Grande do Norte, Natal, Brazil.
João Paulo Matos Santos LimaBioinformatics Multidisciplinary Environment, Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Marilene Henning VainsteinCentro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Universidade Federal do Rio Grande do Sul · BRUniversidade Federal do Rio Grande do Norte · BRUniversidade Federal de Santa Catarina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptococcosis is a fungal infection caused mainly by the pathogenic yeasts

Indexed as

antifungal activitychitinaseCryptococcus neoformansdrug discoveryglycoside hydrolase family 18plumieridinetarget prediction

Identifiers

PMID32983042
PMCPMC7483551
OpenAlexW3081768868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.